9-10 November Nice, France

Transcription

1 PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Practice teaching course in head and neck cancer: focus on comprehensive management 9-10 November

2 Practice teaching course in head and neck cancer: focus on comprehensive management Overview The landscape of treatment options for head and neck cancer patients has expanded considerably in the recent years and combined modality programmes have become the standard of care. Advances in radiotherapy treatment planning and delivery as well as in surgical techniques, and the introduction of molecular targeted agents into clinical practice led to a significant improvement in patient outcomes. This activity will offer the opportunity to review current treatment options for head and neck cancer and to highlight areas of new knowledge and controversy in the multidisciplinary management of head and neck cancer patients. Effective interaction between the multidisciplinary team and participants will be encouraged through clinical case discussions and practical sessions dedicated to treatment planning and delivery. Learning objectives By attending this course, participants will be able to: Define the methodology of the multidisciplinary approach in the management of head and neck cancer patients Summarize current combined modality programmes for the treatment of head and neck cancer patients Discuss the integration of new diagnostic and therapeutic technologies in the clinical management of head and neck cancer patients Target audience International medical oncologists, surgeons and radiation oncologists experienced in the management of head and neck cancer patients. Chair Frederic Peyrade Medical Oncology 1

3 CME Provider EXCEMED is a non profit foundation dedicated, since the last four decades, to the development of highquality medical education programmes all over the world. EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME ) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous. Continuing medical education EXCEMED ( is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), The CME course Practice teaching course in head and neck cancer: focus on comprehensive management" held on 9-10 November 2016 in, is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits. Information on the process to convert EACCME credit to AMA credit can be found at Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. EXCEMED adheres to the principles of the Good CME Practice group (gcmep). 2

4 General information This live educational course takes place at the: 33, Avenue de Valombrose Language The official language of this live educational course is English. CME Provider EXCEMED - Excellence in Medical Education Programme Manager: Silvia Cristofanelli T F silvia.cristofanelli@excemed.org Medical Advisor: Cristina Raimondi cristina.raimondi@libero.it For any logistic support please contact: Meridiano Congress International Congress Manager: Denise Rizzitelli T F denise.rizzitelli@meridiano.it 3

5 Faculty Karen Benezery Radiotherapy Oncology Emmanuelle Besrest Centralised unit of Chemotherapy Preparation (CUCP) Alexandre Bozec Surgery Oncology Gilles Poissonnet Surgery Oncology Esma Saada Medical Oncology Anne Sudaka Biopathology Olivier Dassonville Surgery Oncology Daniel Lam Radiotherapy Oncology Frederic Peyrade Medical Oncology 4

6 Programme

7 Wednesday, 9 November Welcome and introduction F. Peyrade (France) Introduction: Multisciplinary management of HNC F. Peyrade (France) Session I Biopathology and risk factors Session III Radiotherapy Part I L1: Biopathology of head and neck tumor A. Sudaka (France) L2: Risk factors and HPV in head and neck tumor A. Bozec (France) Coffee break L5: Radiotherapy and management of HNC K. Benezery (France) L6: Radiation potentiation: is there any best option? K. Benezery (France) Lunch Session II Surgery Session III Radiotherapy - Part II L3: Surgical management in HNC patients O. Dassonville (France) L4: State of reconstructive surgery G. Poissonnet (France) L7: New technics in radiation D. Lam (France) L8: General toxicities and management D. Lam (France) WG: Open discussion and clinical case presentation Coffee Break Legend L : Lecture WG : Working Group : Site visit 6

8 Thursday, 10 November 2016 Session IV Systemic treatments Session V Practical parallel sessions L9: Current approaches in chemotherapy management of HNC F. Peyrade (France) L10: Induction chemotherapy F. Peyrade (France) L11: First line treatments of recurrent/metastatic HNC E. Saada (France) L12: Second line and beyond treatments of recurrent/metastatic HNC E. Saada (France) Selected clinical cases will be distributed to participants and discussed on the next day End of the first day Real tumor board and clinical case discussion Coffee break Parallel sessions Oncologists Clinical Research Unit visit and open clinical trials at the Centre Antoine Lacassagne E. Besrest (France) Surgeons Video surgery A. Bozec (France) Radiotherapist Visit to the Protontherapy Center Closing remarks F. Peyrade (France) Lunch End of the live educational course 7

9 All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of EXCEMED. This independent programme is made possible thanks to an educational grant received from Merck KGaA, Darmstadt, Germany.

10 Improving the patient's life through medical education EXCEMED - Excellence in Medical Education Headquarters 14, Rue du Rhône Geneva, Switzerland Representative Office Salita di San Nicola da Tolentino 1/b Rome, Italy T F Copyright EXCEMED, All rights reserved.